期刊文献+

血清和胆汁MMP-9、TIMP-1检测在胆管癌诊断中的价值 被引量:10

下载PDF
导出
摘要 目的探讨血清和胆汁基质金属蛋白酶9(MMP-9)、金属蛋白酶组织抑制剂1(TIMP-1)检测在胆管癌中的诊断价值。方法选取45例原发胆管癌患者(胆管癌组)和52例良性胆管疾病患者(良性疾病组),采用ELISA法测定血清和胆汁MMP-9和TIMP-1水平,采用ROC曲线评估血清和胆汁MMP-9、TIMP-1及其比值的诊断效能。结果胆管癌组和良性疾病组血清MMP-9、TIMP-1水平及MMP-9/TIMP-1值无统计学差异(P均>0.05)。胆管癌组胆汁MMP-9水平显著高于良性疾病组(P<0.01),TIMP-1水平显著低于良性疾病组(P<0.01),胆汁MMP-9/TIMP-1值高于良性疾病组(P<0.01)。胆汁MMP-9/TIMP-1值的灵敏度(93.3%)、特异度(75%)和准确度(81.4%)均高于单项指标。结论 MMP-9和TIMP-1参与胆管癌的发生和发展,胆汁MMP-9/TIMP-1值对于胆管癌诊断有良好的价值。
作者 解芳 刘鸿梅
出处 《山东医药》 CAS 北大核心 2016年第25期56-58,共3页 Shandong Medical Journal
  • 相关文献

参考文献11

  • 1覃理灵,石青峰,廖维甲,梅铭惠.sICAM-1、CA19-9、CEA三种肿瘤标志物联合检测在胆管癌诊断中的价值[J].中国实验诊断学,2010,14(3):413-415. 被引量:10
  • 2韩大力,王克山,于甬华.胆管癌的诊断与治疗研究进展[J].山东医药,2013,53(42):100-103. 被引量:13
  • 3Pattanapairoj S,Silsirivanit A,Muisuk K,et al.Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach[J].Clin Biochem,2015,48(10-11):668-673.
  • 4Ricci S,Bruzzese D,DI Carlo A.Evaluation of MMP-2,MMP-9,TIMP-1,TIMP-2,NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer[J].Oncol Lett,2015,10(4):2527-2532.
  • 5Vandooren J,Van den Steen PE,Opdenakker G.Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9(MMP-9):the next decade[J].Crit Rev Biochem Mol Biol,2013,48(3):222-272.
  • 6Itatsu K,Sasaki M,Yamaguchi J,et al.Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha[J].Am J Pathol,2009,174(3):829-841.
  • 7Brown GT,Murray GI.Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis[J].J Pathol,2015,237(3):273-281.
  • 8Thorsen SB,Christensen SL,Würtz SO,et al.Plasma levels of the MMP-9:TIMP-1 complex as prognostic biomarker in breast cancer:a retrospective study[J].BMC Cancer,2013,13(13):598.
  • 9Ries C.Cytokine functions of TIMP-1[J].Cell Mol Life Sci,2014,71(4):659-672.
  • 10Nielsen HJ,Brünner N,Frederiksen C,et al.Plasma tissue inhibitor of metalloproteinases-1(TIMP-1):a novel biological marker in the detection of primary colorectal cancer.Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection[J].Scand J Gastroenterol,2008,43(2):242-248.

二级参考文献37

  • 1何浪,杨耀琴.肿瘤标记物在原发性胆囊癌诊断中的意义[J].同济大学学报(医学版),2004,25(5):438-440. 被引量:9
  • 2周传文,邹晓平.血清CA19—9检测对胰腺癌的诊断意义[J].中华腹部疾病杂志,2002,2(3):210-211. 被引量:3
  • 3杨尽晖,蒋波,吴金术,田秉璋.肿瘤标志物CEA、CA19-9联合检测在胆管癌诊治中的价值[J].中国医师杂志,2005,7(4):552-553. 被引量:6
  • 4Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis[J]. Gastroentremlogy, 1995,108: 865.
  • 5徐玲,赵玉亮.胆管癌及其治疗现状[J].肿瘤基础与临床,2007,20(5):456-458. 被引量:8
  • 6Shaib Y, E1-Serag HB. The epidemiology of cholangiocarcinoma [J]. Semin Liver Dis, 2004,24(2) :115-125.
  • 7Khan SA, Davidson BR, Goldin RD,et al. Guidelines for the diag- nosis and treatment of cholangioeareinoma: an update [ J 1, Gut, 2012,61 (12) : 1657-1669.
  • 8Khan SA, Taylor-Robinson SD, Davidson BR, et al. Cholangio- carcinoma [ J ]. Lancet, 2005,366 ( 9493 ) : 1303-1314.
  • 9Khan SA, Emadossadaty S, Ladep N, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? [J]. J Hepatol, 2012,56(4) :848-854.
  • 10Deofiveira ML, Schulick RD, Nimura Y, eta|. New staging sys- tem and a registry for perihilar cholangiocareinoma[ J]. Hepatolo- gy, 2011,53(4) :1363-1371.

共引文献21

同被引文献86

引证文献10

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部